These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12441896)

  • 1. Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia.
    Brown AJ
    Curr Opin Lipidol; 2002 Dec; 13(6):701-3. PubMed ID: 12441896
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy and clinical trials: ezetimibe.
    Jialal I; Kappagoda T
    Curr Opin Lipidol; 2003 Dec; 14(6):643-6. PubMed ID: 14624143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
    Patel SB
    Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it over for ezetimibe?
    Robinson JG; Davidson M
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy in cholesterol reduction: focus on ezetimibe and statins.
    Grigore L; Norata GD; Catapano AL
    Vasc Health Risk Manag; 2008; 4(2):267-78. PubMed ID: 18561502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
    Descamps OS; De Sutter J; Guillaume M; Missault L
    Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of ezetimibe: a view from outside the receptor.
    Clader JW
    J Med Chem; 2004 Jan; 47(1):1-9. PubMed ID: 14695813
    [No Abstract]   [Full Text] [Related]  

  • 13. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
    Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K
    Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The place of ezetimibe in clinical practice.
    Weston C
    Hosp Med; 2003 Aug; 64(8):473-8. PubMed ID: 12958759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezetimibe: rationale and role in the management of hypercholesterolemia.
    Yatskar L; Fisher EA; Schwartzbard A
    Clin Cardiol; 2006 Feb; 29(2):52-5. PubMed ID: 16506638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving synergy and improvements in cholesterol lowering.
    Cardiovasc J S Afr; 2005; 16(1):63-4. PubMed ID: 15778782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ezetimibe--pharmacokinetics and therapeutics].
    Araújo RG; Casella Filho A; Chagas AC
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():20-4. PubMed ID: 16400393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe: a selective cholesterol absorption inhibitor.
    Nutescu EA; Shapiro NL
    Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.